Novartis-AveXis : A ‘gene’-ius deal?
Novartis AG is wagering high on gene therapy with its proposed acquisition of AveXis Inc. valued at $8.7 billion or...
Novartis AG is wagering high on gene therapy with its proposed acquisition of AveXis Inc. valued at $8.7 billion or...
Walt Disney (DIS) has bid to purchase Sky News in order to ease regulatory affairs in the U.K. over 21st...
Upping its ante against its rivals in the medical and pharma sector, Walgreens has finally completed its acquisition of Rite...
Japanese pharma giant Takeda Pharmaceuticals is said to be planning to bid for London’s leading drug company Shire Pharmaceuticals (Nasdaq:...
Early this year Dominion Energy (D) went public with its intention to buy SCANA Corp (SCG) – the parent company...
Bayer and its U.S. peer Monsanto (MON) achieved a significant milestone after the European Union antitrust regulators approved Bayer’s $63.5...
Salesforce (CRM) agreed to purchase integration software company MuleSoft (MULE) for $6.5 billion in a cash and stock deal. This...
One of the key strategies for The Clorox Company’s solid growth till date has been its ability to diversify its...
The cat-and-mouse game between Broadcom and Qualcomm has come to a sudden halt after President Donald Trump today threw a...
Fitbit, which had a successful IPO in 2015, has seen its own share of ups and downs, including some wide...
Qualcomm (QCOM) – Broadcom (AVGO) battle has off late witnessed some tense and nail-biting moments. The latest twist in this...
Blue Buffalo Pet Products will now have a new home at General Mills. The consumer-foods giant plans to buy the...
Mergers are often like a game of chess. Both sides need to measure each move and plan the counters. And...
Switzerland-based pharma giant Roche has agreed to acquire Flatiron Health for $2.1 billion. Roche, a significant investor in Flatiron, will...